After acquiring LumenR and EndoChoice, Boston Scientific committed to leaning on its endoscopy business to drive growth company-wide, Trefis reports. Here’s what you need to know. 1. In addition to ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Recently, Boston Scientific won U.S. Food and Drug Administration (:FDA) and CE mark approval for the Expect Slimline (SL.V) Needle. The product, which has been launched globally, will be used for ...

Boston Scientific is investing $19 million in a new Galway, Ireland-based RoadRunner endoscopy design facility, Galway Advertiser reports. 1. The company said by 2020 it’ll also invest $19 million in ...

Boston Scientific Corporation BSX recently announced the receipt of CE Mark for its EXALT Model B Single-Use Bronchoscope. Following the regulatory go-ahead, commercialization of the single-use ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...

Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations ...

Boston Scientific will expand its portfolio of products treating gastrointestinal conditions by purchasing EndoChoice Holdings Inc. for $210 million, the company said Tuesday. Boston Scientific—which ...

Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a ...

DUBLIN, Aug. 18, 2021 /PRNewswire/ -- The "The US Endoscopy Device Market: Size & Forecast with Impact Analysis of COVID-19, 2021-2025" report has been added to ResearchAndMarkets.com's offering. The ...

Boston Scientific Corp. is buying Apollo Endosurgery, a medtech company based in Austin, Tex., in a $615 million deal. Apollo makes devices used during endoluminal surgery procedures to close ...